Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Instagram Outage Disrupts Thousands of U.S. Users 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
PALO ALTO, Calif., Aug. 09, 2017 -- Medable Inc., the leading application and analytics platform for healthcare, today announced Tyler Pugsley has joined the company as Vice President of Life Sciences. Pugsley was the Director of Business Development for IBM Watson Health.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/64618bed-5bf5-4b24-b4e0-3961496ec3b8
“Medable is leading a new era in clinical research, in which technology enables clinical trials to be taken directly to patients, anytime, anywhere,” said Dr. Michelle Longmire, Medable CEO. “We are excited that Tyler has joined us in our mission to transform the life sciences industry. With our technology and Tyler’s industry experience, we will usher in a new era marked by globally scaled trial participation and better and more true to life data.”
Pugsley comes with a strong understanding of clinical trials and healthcare analytics, having spent the last two years with IBM Watson where he was instrumental in acquiring new pharma, biotech and Contract Resource Organization (CRO) partners.
“Medable has a truly innovative team and technology which is set to disrupt the $30 billion clinical trial outsourcing market,” said Pugsley. “For years the clinical trials industry has been saddled by legacy technology and workflow inefficiencies.
“Medable’s industry leading platform puts patients first and enables innovation at all levels of clinical trials allowing more efficient real world data collection, monitoring and analysis,” said Pugsley. “As a team, we are passionate about bringing greater value to patients and more effective therapeutics to market.”
ABOUT MEDABLE
Privately-held Palo Alto, California-based Medable provides a comprehensive, secure HIPAA-compliant cloud-based platform purpose-built for healthcare. Medable’s Axon is a “no coding required” solution enabling researchers to deliver smartphone clinical studies on a secure, HIPAA compliant technology stack. Medable’s Synapse is a clinical care app solution for providers and patients. Medable’s Cortex is the fastest way for developers to create scalable, EHR interoperable, HIPAA compliant applications. Medable’s Cerebrum is the first cloud-based machine learning solution created specifically for healthcare apps. For more information visit: www.medable.com
Follow Medable on Twitter: @Medablelinc
The photo is also available via AP PhotoExpress.
Gary Poole, PR Director [email protected]
